{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "8755638", "DateCompleted": {"Year": "1996", "Month": "09", "Day": "23"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0021-9738", "JournalIssue": {"Volume": "98", "Issue": "2", "PubDate": {"Year": "1996", "Month": "Jul", "Day": "15"}}, "Title": "The Journal of clinical investigation", "ISOAbbreviation": "J Clin Invest"}, "ArticleTitle": "Viral infection induces dependence of neuronal M2 muscarinic receptors on cyclooxygenase in guinea pig lung.", "Pagination": {"StartPage": "299", "EndPage": "307", "MedlinePgn": "299-307"}, "Abstract": {"AbstractText": ["Inhibitory M2 muscarinic receptors on parasympathetic nerve endings in the lungs decrease release of acetylcholine, inhibiting vagally induced bronchoconstriction. Neuronal M2 receptor function can be studied using selective agonists and antagonists such as pilocarpine and gallamine. In pathogen-free guinea pigs indomethacin (1 mg/kg) did not alter the effect of either gallamine or pilocarpine, thus in pathogen free animals neuronal M2 muscarinic receptors function independently of cyclooxygenase products. However, in guinea pigs infected with virus, (which causes temporary loss of M2 receptor function), and then allowed to recover for 8 wk (to allow recovery of M2 receptors), indomethacin prevented both gallamine's potentiation and pilocarpine's inhibition of vagally induced bronchoconstriction. This new effect of indomethacin was not blocked by the addition of a 5-lipoxygenase inhibitor, AA861. However, the selective COX II inhibitor, L-745,337, had the same effect as indomethacin. Since exposure to ozone also caused neuronal M2 receptors to become dependent upon cyclooxygenase the effects of viral infection are likely to be due to inflammation. Thus, despite apparent recovery of normal M2 receptor function after viral infection or ozone, linkage of these receptors is chronically altered such that they become largely dependent on the activity of COX II."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21205, USA."}], "Identifier": [], "LastName": "Kahn", "ForeName": "R M", "Initials": "RM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Okanlami", "ForeName": "O A", "Initials": "OA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jacoby", "ForeName": "D B", "Initials": "DB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fryer", "ForeName": "A D", "Initials": "AD"}], "GrantList": [{"GrantID": "ES-03819", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "HL-44727", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-47120", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Clin Invest", "NlmUniqueID": "7802877", "ISSNLinking": "0021-9738"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antibodies, Viral"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzoquinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Indans"}, {"RegistryNumber": "0", "NameOfSubstance": "L 745337"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptor, Muscarinic M2"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Muscarinic"}, {"RegistryNumber": "01MI4Q9DI3", "NameOfSubstance": "Pilocarpine"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "80809-81-0", "NameOfSubstance": "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Prostaglandin-Endoperoxide Synthases"}, {"RegistryNumber": "Q3254X40X2", "NameOfSubstance": "Gallamine Triethiodide"}, {"RegistryNumber": "XXE1CET956", "NameOfSubstance": "Indomethacin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["blood"], "DescriptorName": "Antibodies, Viral"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Benzoquinones"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cyclooxygenase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Electric Stimulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Gallamine Triethiodide"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart Rate"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Indans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Indomethacin"}, {"QualifierName": [], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug effects", "physiology", "physiopathology"], "DescriptorName": "Lung"}, {"QualifierName": ["immunology", "physiopathology", "virology"], "DescriptorName": "Lung Diseases"}, {"QualifierName": [], "DescriptorName": "Macaca mulatta"}, {"QualifierName": ["physiology"], "DescriptorName": "Neurons"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Parainfluenza Virus 1, Human"}, {"QualifierName": ["immunology", "physiopathology"], "DescriptorName": "Paramyxoviridae Infections"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pilocarpine"}, {"QualifierName": ["metabolism"], "DescriptorName": "Prostaglandin-Endoperoxide Synthases"}, {"QualifierName": [], "DescriptorName": "Receptor, Muscarinic M2"}, {"QualifierName": ["physiology"], "DescriptorName": "Receptors, Muscarinic"}, {"QualifierName": ["physiology", "physiopathology"], "DescriptorName": "Vagus Nerve"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "J Pharmacol Exp Ther. 1988 Apr;245(1):59-66", "ArticleIdList": ["2452248"]}, {"Citation": "Br J Pharmacol. 1994 Jun;112(2):588-94", "ArticleIdList": ["8075876"]}, {"Citation": "J Appl Physiol (1985). 1994 Mar;76(3):1088-97", "ArticleIdList": ["8005850"]}, {"Citation": "Neuron. 1993 Aug;11(2):371-86", "ArticleIdList": ["8352945"]}, {"Citation": "Prostaglandins. 1991 Apr;41(4):315-29", "ArticleIdList": ["1651545"]}, {"Citation": "Am Rev Respir Dis. 1991 Oct;144(4):957-8", "ArticleIdList": ["1928974"]}, {"Citation": "J Physiol. 1903 Mar 16;29(2):97-173", "ArticleIdList": ["16992663"]}, {"Citation": "J Physiol. 1981;319:379-92", "ArticleIdList": ["6275074"]}, {"Citation": "J Pharmacol Exp Ther. 1995 Sep;274(3):1531-7", "ArticleIdList": ["7562530"]}, {"Citation": "Am Rev Respir Dis. 1980 Jul;122(1):3-10", "ArticleIdList": ["7406340"]}, {"Citation": "Nature. 1986 Oct 2-8;323(6087):411-6", "ArticleIdList": ["3762692"]}, {"Citation": "Life Sci. 1993;52(5-6):529-36", "ArticleIdList": ["8441332"]}, {"Citation": "J Appl Physiol (1985). 1989 Dec;67(6):2461-5", "ArticleIdList": ["2606854"]}, {"Citation": "Chest. 1989 Dec;96(6):1285-91", "ArticleIdList": ["2531065"]}, {"Citation": "Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1447-51", "ArticleIdList": ["8256883"]}, {"Citation": "Am J Physiol. 1989 Dec;257(6 Pt 1):L361-5", "ArticleIdList": ["2514604"]}, {"Citation": "J Appl Physiol (1985). 1987 May;62(5):1837-44", "ArticleIdList": ["3298196"]}, {"Citation": "Am Rev Respir Dis. 1993 Mar;147(3):559-64", "ArticleIdList": ["8442587"]}, {"Citation": "EMBO J. 1987 Dec 20;6(13):3923-9", "ArticleIdList": ["3443095"]}, {"Citation": "Biochem Biophys Res Commun. 1995 Jun 15;211(2):648-55", "ArticleIdList": ["7540841"]}, {"Citation": "Pulm Pharmacol. 1990;3(1):47-51", "ArticleIdList": ["2152027"]}, {"Citation": "J Appl Physiol Respir Environ Exerc Physiol. 1984 Jul;57(1):129-34", "ArticleIdList": ["6088448"]}, {"Citation": "Am Rev Respir Dis. 1985 Aug;132(2):305-10", "ArticleIdList": ["2992331"]}, {"Citation": "Can J Physiol Pharmacol. 1987 Jul;65(7):1433-41", "ArticleIdList": ["2822214"]}, {"Citation": "J Appl Physiol (1985). 1989 Oct;67(4):1504-11", "ArticleIdList": ["2477356"]}, {"Citation": "BMJ. 1995 May 13;310(6989):1225-9", "ArticleIdList": ["7767192"]}, {"Citation": "Biochem Biophys Res Commun. 1987 Aug 14;146(3):1256-61", "ArticleIdList": ["3619930"]}, {"Citation": "Am Rev Respir Dis. 1988 Jun;137(6):1432-40", "ArticleIdList": ["2849333"]}, {"Citation": "Neuroscience. 1984 Dec;13(4):1359-64", "ArticleIdList": ["6441899"]}, {"Citation": "Br J Pharmacol. 1985 Feb;84(2):309-16", "ArticleIdList": ["2858235"]}, {"Citation": "Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2046-50", "ArticleIdList": ["7510883"]}, {"Citation": "J Appl Physiol (1985). 1988 Jun;64(6):2653-8", "ArticleIdList": ["3042736"]}, {"Citation": "Trends Pharmacol Sci. 1988 Nov;9(11):412-6", "ArticleIdList": ["3078078"]}, {"Citation": "Am J Respir Crit Care Med. 1994 Jul;150(1):28-34", "ArticleIdList": ["8025764"]}, {"Citation": "J Biol Chem. 1994 Nov 25;269(47):29565-70", "ArticleIdList": ["7961942"]}, {"Citation": "Br J Pharmacol. 1991 Jan;102(1):267-71", "ArticleIdList": ["1646059"]}, {"Citation": "Agents Actions. 1991 Sep;34(1-2):270-3", "ArticleIdList": ["1665299"]}, {"Citation": "Lung. 1988;166(6):355-69", "ArticleIdList": ["3148794"]}, {"Citation": "Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6477-80", "ArticleIdList": ["1650470"]}, {"Citation": "Br J Pharmacol. 1984 Dec;83(4):973-8", "ArticleIdList": ["6518347"]}, {"Citation": "Am J Respir Crit Care Med. 1995 Apr;151(4):1040-6", "ArticleIdList": ["7697228"]}]}], "History": [{"Year": "1996", "Month": "7", "Day": "15"}, {"Year": "1996", "Month": "7", "Day": "15", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "7", "Day": "15", "Hour": "0", "Minute": "0"}, {"Year": "1996", "Month": "7", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8755638", "PMC507431", "10.1172/JCI118793"]}}], "PubmedBookArticle": []}